Oxytocin for Osteoarthritis

"Oxytocin can be prescribed for cases of hemorrhage and used to support labour progress, induce uterine contraction, and strengthen childbirth."

"The safety of Oxytocin has been partially validated in Phase 2 clinical trials, therefore our team at Power assigned a rating of 2. There is some data supporting the drug's security profile but no proof that it works therapeutically."

"The primary purpose of the trial, which will run for a 29-minute period after baseline time, is to assess the pharmacodynamics of oxytocin at 256 pg/ml. The secondary outcomes involve measuring oxytocin concentrations in serum samples collected at 64pg/ml and 16 pg/ml respectively; accuracy will be assessed by comparing targeted versus observed values."

"Unfortunately, this clinical trial has closed its recruitment period. Initially posted on December 1st 2022 and amended lastly on May 6th of the same year, it is no longer taking patients for participation. However, if you are seeking another study to join, 456 studies focused on osteoarthritis in knees are currently recruiting as well 53 research projects centered around Oxytocin."

"This scientific investigation requires the participation of 20 people that have been diagnosed with osteoarthritis in their knee and are between 18-75 years old. Additionally, all female subjects must be practicing highly effective birth control techniques such as hormonal methods or double barrier methods for at least a month before receiving any study drugs. Male and female participants should also possess a BMI lower than forty to qualify."

"This trial is seeking volunteers of legal age (18+) and who have not yet reached the age of 75."

"Currently, this medical trial is not actively enrolling patients. Initially posted on December 1st 2022, the trial's last update was made on May 6th 2022. For those searching for other clinical trials related to osteoarthritis or Oxytocin, there are 456 and 53 studies respectively that are currently recruiting participants."